Learn More
CD20 (Obinutuzumab) Recombinant Human Monoclonal Antibody (GA101), Functional Grade, Leinco Technologies™

Description
Specificity: Obinutuzumab (GA101) activity is directed against human CD20. Endotoxin Level: <1.0 EU/mg as determined by the LAL method. Purity: ≥98% monomer by analytical SEC and >95% by SDS Page. Preparation: Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage: Functional grade biosimilar antibodies may be stored sterile as received at 2-8C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80C. Avoid Repeated Freeze Thaw Cycles.
Specifications
Specifications
| Antigen | CD20 (Obinutuzumab) |
| Applications | ELISA, Flow Cytometry, Functional Assay, Western Blot |
| Classification | Recombinant Monoclonal |
| Clone | GA101 |
| Concentration | ≥5.0 mg/mL |
| Conjugate | Functional Grade |
| Formulation | PBS with no preservative; pH 7.2-7.4 |
| Gene Alias | afutuzumab; Gazyva; Gazyvaro; RG7159; RO5072759 |
| Host Species | Human |
| Immunogen | Human lymphoblastoid cell line SB |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.